Practical protocols for stepwise solid‐phase synthesis of cysteine‐containing peptides
- 1 November 2002
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 60 (5) , 292-299
Abstract
This study details a series of conditions that may be applied to ensure ‘safe’ incorporation of cysteine with minimal racemization during automated or manual solid‐phase peptide synthesis. Earlier studies from our laboratories [Han et al. (1997) J. Org. Chem. 62, 4307–4312] showed that several common coupling methods, including those exploiting in situ activating agents such as N‐[(dimethylamino)‐1H‐1,2,3‐triazolo[4,5‐b]pyridin‐1‐ylmethylene]‐N‐methylmethanaminium hexafluorophosphate N‐oxide (HATU), N‐[1H‐benzotriazol‐1‐yl)‐(dimethylamino)methylene]‐N‐methylmethanaminium hexafluorophosphate N‐oxide (HBTU), and (benzotriazol‐1‐yl‐N‐oxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) [all in the presence of N‐methylmorpholine (NMM) or N,N‐diisopropylethylamine (DIEA) as a tertiary amine base], give rise to unacceptable levels (i.e. 5–33%) of cysteine racemization. As demonstrated on the tripeptide model H‐Gly‐Cys‐Phe‐NH2, and on the nonapeptide dihydrooxytocin, the following methods are recommended: O‐pentafluorophenyl (O‐Pfp) ester in DMF; O‐Pfp ester/1‐hydroxybenzotriazole (HOBt) in DMF; N,N′‐diisopropylcarbodiimide (DIPCDI)/HOBt in DMF; HBTU/HOBt/2,4,6‐trimethylpyridine (TMP) in DMF (preactivation time 3.5–7.0 min in all of these cases); and HBTU/HOBt/TMP in CH2Cl2/DMF (1:1) with no preactivation. In fact, several of the aforementioned methods are now used routinely in our laboratory during the automated synthesis of analogs of the 58‐residue protein bovine pancreatic trypsin inhibitor (BPTI). In addition, several highly hindered bases such as 2,6‐dimethylpyridine (lutidine), 2,3,5,6‐tetramethylpyridine (TEMP), octahydroacridine (OHA), and 2,6‐di‐tert‐butyl‐4‐(dimethylamino)pyridine (DB[DMAP]) may be used in place of the usual DIEA or NMM to minimize cysteine racemization even with the in situ coupling protocols.Keywords
This publication has 12 references indexed in Scilit:
- Racemization studies of Fmoc-Ser(tBu)-OH during stepwise continuous-flow solid-phase peptide synthesisTetrahedron Letters, 1998
- Solution- and Solid-Phase Synthesis of N-Protected Glycopeptide Esters of the Benzyl Type as Substrates for Subtilisin-Catalyzed Glycopeptide CouplingsJournal of the American Chemical Society, 1998
- NovelS-Xanthenyl Protecting Groups for Cysteine and Their Applications for theNα-9-Fluorenylmethyloxycarbonyl (Fmoc) Strategy of Peptide Synthesis1-3The Journal of Organic Chemistry, 1997
- [27] Chemical synthesis and nuclear magnetic resonance characterization of partially folded proteins1997
- Cysteine Racemization in Peptide Synthesis: A New and Easy Detection MethodJournal of Peptide Science, 1996
- Optimized methods for chemical synthesis of bovine pancreatic trypsin inhibitor (BPTI) analogues1996
- Peptide Coupling in the Presence of Highly Hindered Tertiary AminesThe Journal of Organic Chemistry, 1996
- Redox‐active bis‐cysteinyl peptides. I. Synthesis of cyclic cystinyl peptides by conventional methods in solution and on solid supportsBiopolymers, 1994
- Effect of Tertiary Bases on O-Benzotriazolyluronium Salt-Induced Peptide Segment CouplingThe Journal of Organic Chemistry, 1994
- Solid‐phase synthesis of bovine pancreatic trypsin inhibitor BPTI) and two analoguesInternational Journal of Peptide and Protein Research, 1992